MediciNova
MNOV
28 hedge funds and large institutions have $7.6M invested in MediciNova in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.06% less ownership
Funds ownership: 10.67% → 10.61% (-0.06%)
7% less funds holding
Funds holding: 30 → 28 (-2)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
31% less capital invested
Capital invested by funds: $11M → $7.6M (-$3.39M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$159K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.4K |
| 3 |
JG
Jain Global
New York
|
+$18.2K |
| 4 |
JP Morgan Chase
New York
|
+$13.1K |
| 5 |
Jane Street
New York
|
+$6.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$77.6K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$55.4K |
| 3 |
Millennium Management
New York
|
-$54.4K |
| 4 |
Barclays
London,
United Kingdom
|
-$38K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$37.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $146 | +$177 | +100 | New |
|
|
NA
27
NewEdge Advisors
New Orleans,
Louisiana
| $4 | – | – | – |
|
|
YIH
28
Y-Intercept (HK)
Hong Kong
| – | -$77.6K | -36,957 | Closed |
|
|
29
Millennium Management
New York
| – | -$54.4K | -25,923 | Closed |
|
|
WA
30
WealthTrust Axiom
Wayne,
Pennsylvania
| – | -$26.3K | -12,500 | Closed |
|
31
Group One Trading
Chicago,
Illinois
| – | -$2.48K | -1,400 | Closed |
|
32
Simplex Trading
Chicago,
Illinois
| – | -$596 | -337 | -95% |
|
MNOV Hedge Fund Activity: Q1 2025 in Review
28 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2025, worth a combined $7.6M — down 31% from $11M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MNOV and 2 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 7 added.
The largest buyer was Citigroup, adding an estimated $159K. The largest seller was Y-Intercept (HK), exiting entirely with an estimated $77.6K sold.
- 28 institutional investors held MediciNova (MNOV) as of Q1 2025, down from 30 in Q4 2024.
- Funds reported $7.6M of MediciNova stock for Q1 2025, down 31% quarter-over-quarter.
- 2 funds opened new MediciNova positions in Q1 2025 and 4 closed out, a net change of -2 holders.
- The largest MediciNova buyer in Q1 2025 was Citigroup, an estimated $159K added.
- The largest MediciNova seller in Q1 2025 was Y-Intercept (HK), an estimated $77.6K sold.
Based on aggregated 13F filings for Q1 2025.